Patents by Inventor Meenal Patel

Meenal Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dust suppression method and system for an autonomous drilling machine
    Patent number: 10024114
    Abstract: A method for dust suppression for an autonomous drilling machine operating at a work site. The method comprises of generating by a perception module perception data of the work site, receiving at least one machine parameter from a machine sensor of the autonomous drilling machine, predicting by a controller a dust level for the autonomous drilling machine at the work site based on one of the perception data or the machine parameter, determining a fluid discharge rate for a fluid discharge unit based on the predicted dust level, and adjusting the fluid discharge rate based on dust level detected during the drilling operation.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: July 17, 2018
    Assignee: Caterpillar Inc.
    Inventors: Nicolas François-Xavier Christophe Vandapel, Michael Karl Wilhelm Happold, Meenal Patel
  • DUST SUPPRESSION METHOD AND SYSTEM FOR AN AUTONOMOUS DRILLING MACHINE
    Publication number: 20170226808
    Abstract: A method for dust suppression for an autonomous drilling machine operating at a work site. The method comprises of generating by a perception module perception data of the work site, receiving at least one machine parameter from a machine sensor of the autonomous drilling machine, predicting by a controller a dust level for the autonomous drilling machine at the work site based on one of the perception data or the machine parameter, determining a fluid discharge rate for a fluid discharge unit based on the predicted dust level, and adjusting the fluid discharge rate based on dust level detected during the drilling operation.
    Type: Application
    Filed: February 4, 2016
    Publication date: August 10, 2017
    Applicant: Caterpillar Inc.
    Inventors: Nicolas François-Xavier Christophe Vandapel, Michael Karl Wilhelm Happold, Meenal Patel
  • Method for operating machines on worksites
    Patent number: 9703290
    Abstract: A method for operating a machine on a worksite is disclosed. The method includes detecting a forward worksite condition and a rearward worksite condition relative to the machine, respectively by a first image capturing module and a second image capturing module. Thereafter, the method includes determination of a measure of effect of the machine on the worksite by comparing the rearward worksite condition with the forward worksite condition. The measure of effect is one of a deviation of an actual machine path with a baseline operational path or an impression left by the machine on the worksite. Finally, controlling one or more parameters related to a movement of the machine over the worksite, based on the measure of effect, is carried out.
    Type: Grant
    Filed: February 13, 2016
    Date of Patent: July 11, 2017
    Assignee: Caterpillar Inc.
    Inventors: Nicolas François-Xavier Christophe Vandapel, Nicholas Chan, Michael Karl Wilhelm Happold, Andrew James Capodieci, Meenal Patel
  • Survival motor neuron gene (SMN2) mRNA constructs for post-transcription regulation
    Patent number: 9394539
    Abstract: The present invention provides compounds and assays for the identification and validation of compounds for use in the treatment of spinal muscular atrophy (SMA), in which said compounds up-regulate the post-transcriptional expression of SMN1 or SMN2.
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: July 19, 2016
    Assignee: PTC THERAPEUTICS, INC.
    Inventors: Sergey V. Paushkin, Anuradha Bhattacharyya, Bansri S. Furia, Meenal Patel, Love Volkova
  • Methods of screening for compounds for treating muscular dystrophy using human ALPHA7 integrin mRNA translation regulation
    Patent number: 9376725
    Abstract: The present invention provides compounds and assays for the identification and validation of compounds for use in the treatment of muscular mystrophy (MD), or a form thereof, in which said compounds increase the post-transcriptional expression of a target gene (i.e., mIGF1, ITGA7, or UTRN).
    Type: Grant
    Filed: April 24, 2014
    Date of Patent: June 28, 2016
    Assignee: PTC THERAPEUTICS, INC.
    Inventors: Westley J. Friesen, Nikolai Naryshkin, Meenal Patel, Charles Romfo, Yuki Tomizawa, Ellen Welch, Jin Zhuo
  • Methods of screening for compounds for treating muscular dystrophy using mIGF1 mRNA translation regulation
    Patent number: 8741572
    Abstract: The present invention provides compounds and assays for the identification and validation of compounds for use in the treatment of muscular mystrophy (MD), or a form thereof, in which said compounds increase the post-transcriptional expression of a target gene (i.e., mIGF1, ITGA7, or UTRN).
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: June 3, 2014
    Assignee: PTC Therapeutics, Inc.
    Inventors: Westley J. Friesen, Nikolai Naryshkin, Meenal Patel, Charles Romfo, Yuki Tomizawa, Ellen Welch, Jin Zhou
  • Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
    Patent number: 8283116
    Abstract: The present invention provides compounds and assays for the identification and validation of compounds for use in the treatment of spinal muscular atrophy (SMA), in which said compounds up-regulate the post-transcriptional expression of SMN1 or SMN2.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: October 9, 2012
    Assignee: PTC Therapeutics, Inc.
    Inventors: Anuradha Bhattacharyya, Bansri S. Furia, Meenal Patel, Sergey V. Paushkin, Love Volkova
  • Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
    Patent number: 8283115
    Abstract: The present invention provides compounds and assays for the identification and validation of compounds for use in the treatment of muscular dystrophy (MD), or a form thereof, in which said compounds increase the post-transcriptional expression of a target gene (i.e., mIGF1, ITGA7, or UTRN).
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: October 9, 2012
    Assignee: PTC Therapeutics, Inc.
    Inventors: Westley J Friesen, Nikolai Naryshkin, Meenal Patel, Charles Romfo, Ellen Welch, Yuki Tomizawa, Jin Zhuo